New cytarabine combinations could overcome toxicities in AML treatment

Compound improves survival in aggressive acute myeloid leukaemia with manageable added toxicity in phase III trial

Immunology highlights from ASH 2014

Engineering stem cell resistance to HIV for two-pronged approach to HIV-associated lymphoma

Post-transplant survival boosted by brentuximab vedotin in lymphoma

Children with aggressive leukaemia experiencing remission with T cell therapy

Frontiers of pharmacokinetics and metabolism in cancer research

Overcoming cancer resistance with enzyme inhibitors

Update on post-operative complications in older patients

Role of the surgeon in geriatric cancer management

Age and chemotherapy choices: risk factors versus benefit?

Challenges of adjuvant chemotherapy in older breast cancer patients